BioSig Merges With Streamex, Signs $1.1B Financing Deal

This merger enhances BioSig’s market reach and influences digital asset markets by targeting a $142 trillion commodity space.

BioSig Technologies and Streamex Exchange Corporation have merged, forming a major entity within the real asset tokenization sector. Henry McPhie, previously CEO at Streamex, now leads the merged company. This merger positions the company as a public first-mover in on-chain commodity finance. The financing aspect, though not confirmed via official filings, indicates a significant market investment.

Streamex becomes a wholly-owned subsidiary of BioSig, with its shareholders gaining 75% of the fully diluted BioSig common stock. This move strengthens their digital commodity tokenization capabilities. The combined company focuses on enabling on-chain, decentralized finance infrastructure for commodities, a potential game changer in DeFi markets.

This merger represents a transformative opportunity for both our company and our shareholders. By joining forces with Streamex, we are unlocking significant growth potential while continuing to advance our existing business. This partnership will expand our market reach, enhance our capabilities, and create even greater opportunities for driving substantial returns. I am incredibly excited about the promising future ahead for our shareholders. — Anthony Amato, Former CEO, BioSig Technologies, Inc.

This shift implicates stronger collaboration within the asset-tokenization space, following historical precedents set by projects such as Paxos Gold. Real-world asset (RWA) tokenization efforts might stimulate protocols by enhancing liquidity and increasing investor engagement.

BioSig’s strategic advisory additions aim at technological scaling and deeper capital markets penetration. Historical tokenization trends suggest positive impacts on EVM-compatible blockchains’ TVL. As developments continue, stakeholders remain attentive to forthcoming infrastructure and product announcements.